Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Midday movers: Apple, Tesla, Eli Lilly and more

Published 01/03/2024, 07:47 AM
Updated 01/03/2024, 11:58 AM
© Reuters

(Updated - January 3, 2024 11:55 AM EST) -- Main U.S. indexes traded lower Wednesday, with investors consolidating ahead of the release of the minutes from the December Federal Reserve meeting.

Here are some of the biggest U.S. stock movers today:

Apple (NASDAQ:AAPL) stock fell 1% after data from research group Counterpoint indicated that the tech giant's iPhone saw its share of the worldwide smartphone market fall in November.

Tesla (NASDAQ:TSLA) stock fell 3.4% after the electric car manufacturer’s sales in China surged by 68.7% on a yearly basis last month, new data from the China Passenger Car Association showed on Wednesday, with the U.S. carmaker facing intense competition in the world’s largest auto market.

Bloomin Brands (BLMN) stock rose 0.4% after the restaurant holding company added two new members to its board, in accordance with an agreement it had reached with activist investor Starboard Value.

Walt Disney (NYSE:DIS) stock declined 0.4% after the entertainment giant said investment firm ValueAct Capital will advise it on strategy and support its director nominees at the 2024 annual shareholder meeting. Separately, Blackwells Capital launched a campaign to nominate three directors and preserve CEO Bob Iger’s “value creation vision.”

SoFi Technologies (NASDAQ:SOFI) stock fell 12.3% after Keefe, Bruyette & Woods downgraded its rating on the online personal finance company to ‘underperform’ from ‘market perform’, citing its recent outperformance.

Coinbase (NASDAQ:COIN) stock fell 1.4%, with the cryptocurrency exchange suffering as bitcoin, the world’s favorite digital currency, retreated sharply.

Verizon Communications (NYSE:VZ) stock rose 1.2% after KeyBanc upgraded its stance on the telecoms giant to ‘overweight’ from ‘sector weight’, seeing the potential for it to outshine the sector.

Agios Pharma (NASDAQ:AGIO) stock rose 4.4% after the biotech announced positive results from a Phase 3 trial of a treatment for a rare blood disorder.

AIG (NYSE:AIG) stock fell 0.4% after Reuters reported that the company was the lead insurer on a $130 million "all-risks" policy for the Japan Airlines airplane which collided with another plane at Tokyo's Haneda airport.

Keurig Dr Pepper Inc. (NASDAQ:KDP) stock fell 2% after it was cut to 'equal-weight' from 'overweight' at Morgan Stanley. Analysts said they were moving to the sideline following recent gains.

CBRE Group (NYSE:CBRE) stock fell 4% after Evercore ISI downgraded it to 'in line' from 'outperform'.

Eli Lilly (NYSE:LLY) stock rose 3.3%, leading a surge in pharma stocks. Amgen (NASDAQ:AMGN) climbed 1.4% and Merck (MRK) climbed 1.7%.

Additional reporting by Louis Juricic

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.